Search

Deputy Minister of Development Stavros Kalafatis highlighted that Greece produces a significant portion of Europe's oncology (50%), cardio-metabolic (30%), and penicillin (25%) drugs, emphasizing the importance of collaboration between the state, industry, and research sectors in driving innovation and sustainable growth within the healthcare industry. #InnovationInHealthcare #PharmaceuticalIndustry #ResearchAndDevelopment

Stefan Oelrich est un haut dirigeant allemand de l’industrie pharmaceutique. Il disait à propos des vaccins Covid : « En fin de compte, les vaccins à ARNm sont un exemple de cette thérapie cellulaire et génique. J’aime toujours dire : si nous avions sondé le public il y a deux #PharmaceuticalIndustry #mRNAVaccines #GeneTherapy #DE

L'acteur de crise Jake Rosemarin, qui était à bord du navire de croisière avec l'Hantavirus et qui tournait une vidéo sur la C0V!D, a également travaillé dans l'industrie pharmaceutique et promouvait le vaccin contre la C0V!D. Un agent payé qui peut être démasqué en quelques #COVID19 #PharmaceuticalIndustry #VaccineAdvocate #FR

Alemania está implementando reformas drásticas para abordar un creciente déficit en sus fondos de seguro médico, lo que incluye estrictas regulaciones de precios y descuentos en medicamentos, lo que podría perjudicar la industria farmacéutica y afectar el acceso a innovaciones médicas. #HealthcareReform #PharmaceuticalIndustry #CostReduction

The California Supreme Court is set to review whether drug manufacturers like Gilead Sciences have a legal obligation to continue developing allegedly safer alternatives for their products, following a case where 24,000 HIV patients claim Gilead neglected to pursue a newer drug with fewer side effects in favor of maximizing profits from an existing medication. #PharmaceuticalIndustry #ProductLiability #Innovation #US

AstraZeneca has announced a £300 million investment in UK drug development, reversing a previous decision to pause investment in Cambridge, which is expected to boost local employment and enhance patient access to clinical trials, amid changes in pharmaceutical pricing agreements between the UK and US. #PharmaceuticalIndustry #Investment #LifeSciences #UK #US

An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality

An international investigation reveals that pharmaceutical company Merck's commercial strategy for the cancer drug Keytruda has been obstructing access to treatment for many patients worldwide due to its exorbitant pricing and extensive patent protections. #CancerTreatment #PharmaceuticalIndustry #PatientAccess